Aoxing Pharmaceutical Company(AOXG)
$0.00-0.00 (-23.33%)
AOXG
Aoxing Pharmaceutical Company financials statements
$0.00
At close:-0.00 (-23.33%)
Aoxing Pharmaceutical Company (AOXG) Ratios
37 Followers
Aoxing Pharmaceutical Company Ratios
AOXG's free cash flow for Q2 2026 was $-800.00. For the 2026 fiscal year, AOXG's free cash flow was increased by $0.00 and operating cash flow was $-801.00. See a summary of the company’s cash flow.
| Ratios | Q2 26 | Q1 26 | Q3 17 | Q2 17 | Q1 17 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.96 | 1.05 | ― | ― | ― |
| Quick Ratio | 0.96 | 1.05 | ― | ― | ― |
| Cash Ratio | 0.18 | 0.20 | ― | ― | ― |
| Solvency Ratio | -0.09 | -0.02 | ― | ― | ― |
| Operating Cash Flow Ratio | -0.01 | -0.87 | ― | ― | ― |
| Short-Term Operating Cash Flow Coverage | -0.01 | -1.02 | ― | ― | ― |
| Net Current Asset Value | $ -5.47K | $ 5.74K | ― | ― | ― |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.82 | 0.81 | ― | ― | ― |
| Debt-to-Equity Ratio | -18.82 | 17.82 | ― | ― | ― |
| Debt-to-Capital Ratio | 1.06 | 0.95 | ― | ― | ― |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | ― | ― | ― |
| Financial Leverage Ratio | -23.03 | 21.97 | ― | ― | ― |
| Debt Service Coverage Ratio | -0.11 | -0.02 | ― | ― | ― |
| Interest Coverage Ratio | 0.00 | 0.00 | ― | ― | ― |
| Debt to Market Cap | 0.08 | 0.05 | ― | ― | ― |
| Interest Debt Per Share | 0.00 | 0.00 | ― | ― | ― |
| Net Debt to EBITDA | -7.06 | -32.08 | ― | ― | ― |
| Profitability Margins | |||||
| Gross Profit Margin | 98.75% | 0.00% | ― | ― | ― |
| EBIT Margin | -65.07% | -117.26% | ― | ― | ― |
| EBITDA Margin | -65.07% | -117.26% | ― | ― | ― |
| Operating Profit Margin | -65.07% | -117.26% | ― | ― | ― |
| Pretax Profit Margin | -65.08% | -117.21% | ― | ― | ― |
| Net Profit Margin | -65.08% | -117.21% | ― | ― | ― |
| Continuous Operations Profit Margin | -65.08% | -117.21% | ― | ― | ― |
| Net Income Per EBT | 100.00% | 100.00% | ― | ― | ― |
| EBT Per EBIT | 100.02% | 99.96% | ― | ― | ― |
| Return on Assets (ROA) | -8.90% | -1.94% | ― | ― | ― |
| Return on Equity (ROE) | 204.96% | -42.51% | ― | ― | ― |
| Return on Capital Employed (ROCE) | 204.88% | -42.53% | ― | ― | ― |
| Return on Invested Capital (ROIC) | -11.50% | -2.26% | ― | ― | ― |
| Return on Tangible Assets | -8.90% | -1.94% | ― | ― | ― |
| Earnings Yield | -0.89% | -0.12% | ― | ― | ― |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | ― | ― | ― |
| Payables Turnover | 0.00 | 0.00 | ― | ― | ― |
| Inventory Turnover | 0.00 | 0.00 | ― | ― | ― |
| Fixed Asset Turnover | 0.00 | 0.00 | ― | ― | ― |
| Asset Turnover | 0.14 | 0.02 | ― | ― | ― |
| Working Capital Turnover Ratio | 127.97 | 0.00 | ― | ― | ― |
| Cash Conversion Cycle | 0.00 | 0.00 | ― | ― | ― |
| Days of Sales Outstanding | 0.00 | 0.00 | ― | ― | ― |
| Days of Inventory Outstanding | 0.00 | 0.00 | ― | ― | ― |
| Days of Payables Outstanding | 0.00 | 0.00 | ― | ― | ― |
| Operating Cycle | 0.00 | 0.00 | ― | ― | ― |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | ― | ― | ― |
| Free Cash Flow Per Share | -0.00 | -0.00 | ― | ― | ― |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | ― | ― | ― |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | ― | ― | ― |
| Operating Cash Flow Coverage Ratio | -0.01 | -1.02 | ― | ― | ― |
| Operating Cash Flow to Sales Ratio | -0.05 | -50.19 | ― | ― | ― |
| Free Cash Flow Yield | -0.06% | -4.98% | ― | ― | ― |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -28.08 | -215.00 | ― | ― | ― |
| Price-to-Sales (P/S) Ratio | 73.09 | 1008.01 | ― | ― | ― |
| Price-to-Book (P/B) Ratio | -230.19 | 365.59 | ― | ― | ― |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1572.49 | -20.08 | ― | ― | ― |
| Price-to-Operating Cash Flow Ratio | -1570.52 | -20.09 | ― | ― | ― |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | ― | ― | ― |
| Enterprise Value Multiple | -119.39 | -891.71 | ― | ― | ― |
| Enterprise Value | 1.34M | 2.17M | ― | ― | ― |
| EV to EBITDA | -119.39 | -891.71 | ― | ― | ― |
| EV to Sales | 77.68 | 1045.62 | ― | ― | ― |
| EV to Free Cash Flow | -1671.29 | -20.83 | ― | ― | ― |
| EV to Operating Cash Flow | -1669.20 | -20.83 | ― | ― | ― |
| Tangible Book Value Per Share | -0.00 | 0.00 | ― | ― | ― |
| Shareholders’ Equity Per Share | -0.00 | 0.00 | ― | ― | ― |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | ― | ― | ― |
| Revenue Per Share | 0.00 | 0.00 | ― | ― | ― |
| Net Income Per Share | -0.00 | -0.00 | ― | ― | ― |
| Tax Burden | 1.00 | 1.00 | ― | ― | ― |
| Interest Burden | 1.00 | 1.00 | ― | ― | ― |
| Research & Development to Revenue | 0.00 | 0.00 | ― | ― | ― |
| SG&A to Revenue | 1.64 | 2.17 | ― | ― | ― |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | ― | ― | ― |
| Income Quality | 0.07 | 42.82 | ― | ― | ― |
Currency in USD

